Paul Tetteh Asare
Paul Tetteh Asare
1Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland
2Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
3University of Basel, Basel, Switzerland
4Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
1,2,3,4,†,‡,
Chi-Hsien Lee
Chi-Hsien Lee
1Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland
2Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
3University of Basel, Basel, Switzerland
1,2,3,†,‡,
Vera Hürlimann
Vera Hürlimann
2Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
3University of Basel, Basel, Switzerland
2,3,†,#,
Youzheng Teo
Youzheng Teo
1Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland
1,
Aline Cuénod
Aline Cuénod
4Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
5Clinical Bacteriology and Mycology, University Hospital of Basel, Basel, Switzerland
4,5,†,#,
Nermin Akduman
Nermin Akduman
6Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany
7Cluster of Excellence ‘Controlling Microbes to Fight Infections', University of Tübingen, Tübingen, Germany
6,7,
Cordula Gekeler
Cordula Gekeler
6Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany
7Cluster of Excellence ‘Controlling Microbes to Fight Infections', University of Tübingen, Tübingen, Germany
6,7,
Afrizal Afrizal
Afrizal Afrizal
8Functional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany
8,
Myriam Corthesy
Myriam Corthesy
9Institute of Microbiology of the University of Lausanne, University Hospital Centre (CHUV), Lausanne, Switzerland
9,
Claire Kohout
Claire Kohout
10Duchossois Family Institute, Division of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States
10,
Vincent Thomas
Vincent Thomas
11BioAster, Paris, France
11,
Tomas de Wouters
Tomas de Wouters
12PharmaBiome AG, Schlieren, Switzerland
12,
Gilbert Greub
Gilbert Greub
9Institute of Microbiology of the University of Lausanne, University Hospital Centre (CHUV), Lausanne, Switzerland
9,
Thomas Clavel
Thomas Clavel
8Functional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany
8,
Eric G Pamer
Eric G Pamer
10Duchossois Family Institute, Division of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States
10,
Adrian Egli
Adrian Egli
4Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
5Clinical Bacteriology and Mycology, University Hospital of Basel, Basel, Switzerland
4,5,†,#,
Lisa Maier
Lisa Maier
6Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany
7Cluster of Excellence ‘Controlling Microbes to Fight Infections', University of Tübingen, Tübingen, Germany
6,7,
Pascale Vonaesch
Pascale Vonaesch
1Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland
2Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
3University of Basel, Basel, Switzerland
1,2,3,*
1Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland
2Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
3University of Basel, Basel, Switzerland
4Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
5Clinical Bacteriology and Mycology, University Hospital of Basel, Basel, Switzerland
6Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany
7Cluster of Excellence ‘Controlling Microbes to Fight Infections', University of Tübingen, Tübingen, Germany
8Functional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany
9Institute of Microbiology of the University of Lausanne, University Hospital Centre (CHUV), Lausanne, Switzerland
10Duchossois Family Institute, Division of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States
11BioAster, Paris, France
12PharmaBiome AG, Schlieren, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Pascale Vonaesch pascale.vonaesch@unil.ch
†Present addresses: Paul Tetteh Asare, Gnubiotics Sciences AG, SuperLab Suisse, Lausanne, Switzerland
†
Chi-Hsien Lee, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium
†
Vera Hürlimann, PharmaBiome AG, Schlieren, Switzerland
†
Adrian Egli and Aline Cuénod, Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
‡These authors have contributed equally to this work
Received 2023 Apr 18; Accepted 2023 Apr 19; Collection date 2023.
Keywords: human gut microbiota, Clostridia, MALDI-TOF MS, commensal bacteria, anaerobic, bacterial identification, culturomics, next-generation probiotics
Copyright © 2023 Asare, Lee, Hürlimann, Teo, Cuénod, Akduman, Gekeler, Afrizal, Corthesy, Kohout, Thomas, de Wouters, Greub, Clavel, Pamer, Egli, Maier and Vonaesch.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.